4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Emergent BioSolutions Inc. (EBS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Gaithersburg, United States with about 900 employees. Its market capitalization is roughly $407 million. In the fiscal year ended 2025-12-31, EBS reported $705M in revenue and $53M in net income.
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commercial Products, MCM Products, and All Other Revenues segments.
Interactive charts & full statements → Open the EBS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $705M | $1.0B | $1.0B | $1.1B |
| Gross Profit | $379M | $332M | $318M | $383M |
| Operating Income (EBIT) | $112M | ($82M) | ($202M) | ($163M) |
| Net Income | $53M | ($191M) | ($760M) | ($212M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $150M | $144M | $222M | $130M | $209M | — |
| Gross Profit | $78M | $59M | $136M | $63M | $121M | — |
| Operating Income (EBIT) | $10M | ($16M) | $76M | $2M | $50M | — |
| Net Income | $7M | ($55M) | $51M | ($12M) | $68M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $1.3B | $1.4B | $1.8B | $3.2B | — |
| Total Liabilities | $796M | $907M | $1.2B | $1.8B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EBS viewer.
About TickerBase · Data methodology & sources